News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
214,838 Results
Type
Article (10034)
Company Profile (121)
Press Release (204683)
Section
Business (64788)
Career Advice (1559)
Deals (11268)
Drug Delivery (26)
Drug Development (36618)
Employer Resources (83)
FDA (4980)
Job Trends (5248)
News (118087)
Policy (8773)
Tag
Academia (672)
Allergies (33)
Alliances (14774)
Alzheimer's disease (362)
Approvals (4963)
Bankruptcy (76)
Best Places to Work (4457)
Biotechnology (84)
Cancer (377)
Career advice (1274)
Cell therapy (73)
Clinical research (30472)
Collaboration (116)
Compensation (106)
COVID-19 (643)
C-suite (41)
Data (529)
Diabetes (61)
Diagnostics (855)
Earnings (25466)
Employer resources (70)
Events (37706)
Executive appointments (145)
FDA (5209)
Funding (98)
Gene therapy (42)
GLP-1 (191)
Government (912)
Healthcare (4521)
Infectious disease (667)
Inflammatory bowel disease (41)
Interviews (315)
IPO (6141)
Job creations (971)
Job search strategy (1041)
Layoffs (72)
Legal (1255)
Lung cancer (74)
Management (34)
Manufacturing (67)
Medical device (2093)
Medtech (2094)
Mergers & acquisitions (5218)
Metabolic disorders (155)
Neuroscience (462)
NextGen Class of 2024 (1758)
Non-profit (1063)
Northern California (650)
Obesity (78)
Opinion (64)
People (21207)
Pharmaceutical (40)
Phase I (8721)
Phase II (13595)
Phase III (10452)
Pipeline (227)
Postmarket research (868)
Preclinical (3312)
Radiopharmaceuticals (105)
Rare diseases (88)
Real estate (1596)
Recruiting (40)
Regulatory (7048)
Research institute (507)
Resumes & cover letters (297)
Southern California (566)
Startups (1044)
United States (5470)
Vaccines (106)
Weight loss (37)
Date
Today (44)
Last 7 days (295)
Last 30 days (1539)
Last 365 days (14322)
2024 (13119)
2023 (16010)
2022 (20071)
2021 (21731)
2020 (19377)
2019 (14811)
2018 (10907)
2017 (11385)
2016 (10109)
2015 (12202)
2014 (9134)
2013 (6756)
2012 (6856)
2011 (7020)
2010 (6523)
Location
Africa (303)
Asia (14938)
Australia (2193)
California (1373)
Canada (449)
China (132)
Colorado (54)
Connecticut (53)
Delaware (37)
Europe (29454)
Florida (159)
Georgia (45)
Illinois (96)
Indiana (65)
Kansas (50)
Maryland (232)
Massachusetts (1132)
Michigan (40)
Minnesota (65)
New Jersey (520)
New York (494)
North Carolina (306)
Northern California (650)
Ohio (53)
Pennsylvania (347)
South America (360)
Southern California (566)
Texas (185)
Virginia (39)
Washington State (79)
214,838 Results for "sk biopharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SK Biopharmaceuticals Seals 1st Actinium-225-Based Collaborative Research Agreement with Korea Institute of Radiological and Medical Sciences as Steps Toward Becoming Global Radiopharmaceutical Therapy Player
November 19, 2024
·
5 min read
SK Biopharmaceuticals Announces 100,000 Patients Globally Have Been Treated with Cenobamate Through Sales of XCOPRI® and ONTOZRY® in the U.S., Europe, Israel, and Canada
SK Biopharmaceuticals Co., Ltd. today announced more than 100,000 patients have been treated globally with cenobamate, an anti-seizure medication (ASM) developed by SK Biopharmaceuticals and its U.S. subsidiary SK Life Science, Inc.
March 11, 2024
·
13 min read
News
Full-Life Technologies, SK Biopharmaceuticals Enter Licensing Agreement for Novel Therapeutic Targeting Multiple Solid Tumors
July 16, 2024
·
4 min read
Press Releases
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia
October 24, 2024
·
3 min read
Press Releases
South Korea’s SK bioscience Completes Acquisition of Germany’s CDMO IDT Biologika
October 2, 2024
·
6 min read
Press Releases
SK pharmteco Invests $260 Million to Expand Global Small Molecule and Peptide Production
September 30, 2024
·
3 min read
SK Biopharmaceuticals Makes Big Bets to be ‘Big Biotech’
SK Biopharmaceuticals announced that it has unveiled its new strategy that will enable the company take a leap toward becoming a global “big biotech.”
July 17, 2023
·
3 min read
Business
Ferring Pharmaceuticals and SK Pharmteco Enter into Commercial Gene Therapy Manufacturing Deal
Ferring Pharmaceuticals and SK pharmteco today announced an agreement to scale up commercial manufacturing capacity for the drug substance of Ferring’s intravesical non-replicating gene therapy ADSTILADRIN (nadofaragene firadenovec-vncg) for ensuring long-term future supply.
April 18, 2024
·
10 min read
SK Biopharmaceuticals Assembles ‘Board of Prominent Experts’ to Boost Growth, Innovation
SK Biopharmaceuticals, a global biotech company, announced the formation of its Scientific Advisory Board, comprising of five prominent experts in oncology, epilepsy, and radiopharmaceutical therapy.
August 2, 2023
·
4 min read
Pharm Country
SK Life Science Announces Data Presentations for XCOPRI® (cenobamate tablets) CV at the 2024 American Academy of Neurology Annual Meeting
SK Life Science, Inc. today announced the schedule for two oral and six poster presentations at the American Academy of Neurology (AAN) Annual Meeting taking place April 13–18, 2024, virtually and in-person in Denver, Colorado.
April 9, 2024
·
11 min read
1 of 21,484
Next
